[HTML] degruyter.com

[HTML][HTML] Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - Journal of Translational Internal Medicine, 2016 - degruyter.com
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the
opportunities to use this molecule in new pharmaceutical formulations to combat type 2 …
被引用次数：7 相关文章

Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - Journal of Translational Internal Medicine, 2016 - europepmc.org
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the
opportunities to use this molecule in new pharmaceutical formulations to combat type 2 …

Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - degruyter.com
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the
opportunities to use this molecule in new pharmaceutical formulations to combat type 2 …
[PDF] core.ac.uk

[PDF][PDF] Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - core.ac.uk
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the
opportunities to use this molecule in new pharmaceutical formulations to combat type 2 …

Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - JOURNAL OF TRANSLATIONAL INTERNAL …, 2016 - air.unimi.it
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the
opportunities to use this molecule in new pharmaceutical formulations to combat type 2 …
[HTML] nih.gov

[HTML][HTML] Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - Journal of Translational Internal Medicine, 2016 - ncbi.nlm.nih.gov
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the
opportunities to use this molecule in new pharmaceutical formulations to combat type 2 …

Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - Journal of translational internal …, 2016 - pubmed.ncbi.nlm.nih.gov
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the
opportunities to use this molecule in new pharmaceutical formulations to combat type 2 …

[引用][C] Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - Journal of Translational Internal Medicine - sciendo.com
DOI: https://doi. org/10.1515/jtim-2016-0026© 2016 Stefano Benedini, Livio Luzi This article
is distributed under the terms of the Creative Commons Attribution Non-Commercial …
[PDF] unimi.it

[PDF][PDF] Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - air.unimi.it
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the
opportunities to use this molecule in new pharmaceutical formulations to combat type 2 …

Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

S Benedini, L Luzi - Journal of Translational Internal Medicine, 2016 - europepmc.org
Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the
opportunities to use this molecule in new pharmaceutical formulations to combat type 2 …